| Bioactivity | MRTF/SRF-IN-1 (example 41) is an inhibitor of both myocardin-related transcription factor and serum response factor (MRTF/SRF). MRTF/SRF-IN-1 can be used for research for preventing cancer and fibrosis[1]. | ||||||||||||
| Name | MRTF/SRF-IN-1 | ||||||||||||
| CAS | 1922098-90-5 | ||||||||||||
| Formula | C24H19ClF3N3O2 | ||||||||||||
| Molar Mass | 473.87 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Larsen Scott D, et al. Preparation of substituted piperidine-3-carboxamides as inhibitors of myocardin-related transcription factor and serum response factor (MTRF/SRF)-mediated gene transcription. World Intellectual Property Organization, WO2016073847 A2. 2016-05-12. |
MRTF/SRF-IN-1
CAS: 1922098-90-5 F: C24H19ClF3N3O2 W: 473.87
MRTF/SRF-IN-1 (example 41) is an inhibitor of both myocardin-related transcription factor and serum response factor (MRT
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.